| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -5.88% | +1.00% | -6.88% | -6.88% | — |
| 14d | 1 | +100.00% | -14.84% | -0.17% | -14.67% | -14.67% | — |
| 30d | 1 | +100.00% | -32.22% | -5.50% | -26.72% | -26.72% | — |
| 60d | 1 | +100.00% | -27.89% | +3.27% | -31.16% | -31.16% | — |
| 90d | 1 | +100.00% | -38.71% | +8.16% | -46.88% | -46.88% | — |
| 180d | 1 | +100.00% | -37.54% | +13.12% | -50.66% | -50.66% | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KROS KEROS THERAPEUTICS, INC. | SALE Chief Legal Officer | 4,485 | $10.29 | $46.2K | 35,770 | Aug 18, 2026 | Aug 20, 2026 ↗ | View → |
| KROS KEROS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Feb 24, 2026 | Mar 27, 2026 ↗ | View → |
| KROS KEROS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| KROS KEROS THERAPEUTICS, INC. | SALE SVP, General Counsel | 4,745 | $16.35 | $77.6K | 39,755 | Feb 18, 2026 | Feb 20, 2026 ↗ | View → |